These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND IDH2, P48735, 3418, ENSG00000182054, IDHM, mNADP-IDH, IDH, IDP, ICD-M AND Treatment
24 results:

  • 1. Radiogenomic profiling of global DNA methylation associated with molecular phenotypes and immune features in glioma.
    Zhuang Z; Lin J; Wan Z; Weng J; Yuan Z; Xie Y; Liu Z; Xie P; Mao S; Wang Z; Wang X; Huang M; Luo Y; Yu H
    BMC Med; 2024 Sep; 22(1):352. PubMed ID: 39218882
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Regorafenib and glioblastoma: a literature review of preclinical studies, molecular mechanisms and clinical effectiveness.
    Mongiardi MP; Pallini R; D'Alessandris QG; Levi A; Falchetti ML
    Expert Rev Mol Med; 2024 Apr; 26():e5. PubMed ID: 38563164
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. M
    Peng Y; Liu QZ; Xu D; Fu JY; Zhang LX; Qiu L; Lin JG
    Biochem Pharmacol; 2023 Nov; 217():115856. PubMed ID: 37838274
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Glioma arising in the setting of mismatch repair deficiency-rare or are we missing it?
    Goyal A; Rao S; Rishi KS; Ramaswamy V; Sadashiva N; Santosh V
    Childs Nerv Syst; 2024 Jan; 40(1):233-237. PubMed ID: 37733272
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Cost-effectiveness of preventive aspirin use and intensive downstaging polypectomy in patients with familial adenomatous polyposis: A microsimulation modeling study.
    Saito E; Mutoh M; Ishikawa H; Kamo K; Fukui K; Hori M; Ito Y; Chen Y; Sigel B; Sekiguchi M; Hemmi O; Katanoda K
    Cancer Med; 2023 Sep; 12(18):19137-19148. PubMed ID: 37649281
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Mismatch Repair Deficiency and Lynch Syndrome Among Adult Patients With Glioma.
    Benusiglio PR; Elder F; Touat M; Perrier A; Sanson M; Colas C; Guerrini-Rousseau L; Tran DT; Trabelsi N; Carpentier C; Marie Y; Adam C; Bernier M; Cazals-Hatem D; Mokhtari K; Tran S; Mathon B; Capelle L; Dhooge M; Idbaih A; Alentorn A; Houillier C; Dehais C; Hoang-Xuan K; Cuzzubbo S; Carpentier A; Duval A; Coulet F; Bielle F
    JCO Precis Oncol; 2023 May; 7():e2200525. PubMed ID: 37262394
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Mismatch repair-deficient glioma with spatially distinct idh-mutant and idh-wild type components arising in the setting of Lynch syndrome.
    Tan H; Nerison C; Stateler C; Bowden SG; Raslan AM; Ambady P; Barajas RF; Wood MD
    Cold Spring Harb Mol Case Stud; 2023 Apr; 9(2):. PubMed ID: 37076313
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. idh2, a novel target of OGT, facilitates glucose uptake and cellular bioenergy production via NF-κB signaling to promote colorectal cancer progression.
    He X; Wu N; Li R; Zhang H; Zhao Y; Nie Y; Wu J
    Cell Oncol (Dordr); 2023 Feb; 46(1):145-164. PubMed ID: 36401762
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Intensive endoscopic resection for downstaging of polyp burden in patients with familial adenomatous polyposis (J-FAPP Study III): a multicenter prospective interventional study.
    Ishikawa H; Yamada M; Sato Y; Tanaka S; Akiko C; Tajika M; Doyama H; Takayama T; Ohda Y; Horimatsu T; Sano Y; Tanakaya K; Ikematsu H; Saida Y; Ishida H; Takeuchi Y; Kashida H; Kiriyama S; Hori S; Lee K; Tashiro J; Kobayashi N; Nakajima T; Suzuki S; Mutoh M;
    Endoscopy; 2023 Apr; 55(4):344-352. PubMed ID: 36216266
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Sporadic and Lynch syndrome-associated mismatch repair-deficient brain tumors.
    Kim H; Lim KY; Park JW; Kang J; Won JK; Lee K; Shim Y; Park CK; Kim SK; Choi SH; Kim TM; Yun H; Park SH
    Lab Invest; 2022 Feb; 102(2):160-171. PubMed ID: 34848827
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. cancer-associated idh mutations induce Glut1 expression and glucose metabolic disorders through a PI3K/Akt/mTORC1-Hif1α axis.
    Liu X; Yamaguchi K; Takane K; Zhu C; Hirata M; Hikiba Y; Maeda S; Furukawa Y; Ikenoue T
    PLoS One; 2021; 16(9):e0257090. PubMed ID: 34516556
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Wild-type idh2 protects nuclear DNA from oxidative damage and is a potential therapeutic target in colorectal cancer.
    Qiao S; Lu W; Glorieux C; Li J; Zeng P; Meng N; Zhang H; Wen S; Huang P
    Oncogene; 2021 Sep; 40(39):5880-5892. PubMed ID: 34349242
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Challenges and Solutions in Choosing the Surgical treatment in Patients with Complicated Colon cancer Operated in an Emergency - A Retrospective Study.
    Mihailov R; Firescu D; Voicu D; Constantin GB; Beznea A; Rebegea L; Șerban C; Panaitescu E; Bîrlă R; Patraşcu T
    Chirurgia (Bucur); 2021; 116(3):312-330. PubMed ID: 34191712
    [No Abstract]    [Full Text] [Related]  

  • 14. Suppression of oxidative phosphorylation and idh2 sensitizes colorectal cancer to a naphthalimide derivative and mitoxantrone.
    Ge C; Wang Y; Feng Y; Wang S; Zhang K; Xu X; Zhang Z; Zhao Y; Wang Y; Gao L; Dai F; Xie S; Wang C
    Cancer Lett; 2021 Oct; 519():30-45. PubMed ID: 34166768
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Differential expression of the BCAT isoforms between breast cancer subtypes.
    Shafei MA; Flemban A; Daly C; Kendrick P; White P; Dean S; Qualtrough D; Conway ME
    Breast Cancer; 2021 May; 28(3):592-607. PubMed ID: 33367952
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Vitamin C in combination with inhibition of mutant idh1 synergistically activates TET enzymes and epigenetically modulates gene silencing in colon cancer cells.
    Gerecke C; Schumacher F; Berndzen A; Homann T; Kleuser B
    Epigenetics; 2020 Mar; 15(3):307-322. PubMed ID: 31505989
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Biologics, Immunotherapy, and Future Directions in the treatment of Advanced Cholangiocarcinoma.
    Saeed A; Park R; Al-Jumayli M; Al-Rajabi R; Sun W
    Clin Colorectal Cancer; 2019 Jun; 18(2):81-90. PubMed ID: 30905548
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Supra-physiological concentration of glyoxylate inhibits proliferation of human colon cancer cells through oxidative stress.
    Patra T; Ghosh P; Alam N; Murmu N
    Life Sci; 2018 Aug; 207():80-89. PubMed ID: 29852189
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. M
    Peng Y; Qiu L; Xu D; Zhang L; Yu H; Ding Y; Deng L; Lin J
    Life Sci; 2017 Sep; 185():63-72. PubMed ID: 28751160
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Pan-mutant idh1 inhibitor BAY 1436032 for effective treatment of idh1 mutant astrocytoma in vivo.
    Pusch S; Krausert S; Fischer V; Balss J; Ott M; Schrimpf D; Capper D; Sahm F; Eisel J; Beck AC; Jugold M; Eichwald V; Kaulfuss S; Panknin O; Rehwinkel H; Zimmermann K; Hillig RC; Guenther J; Toschi L; Neuhaus R; Haegebart A; Hess-Stumpp H; Bauser M; Wick W; Unterberg A; Herold-Mende C; Platten M; von Deimling A
    Acta Neuropathol; 2017 Apr; 133(4):629-644. PubMed ID: 28124097
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.